| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/14/2003 | EP1310507A2 Novel peptide nucleic acids |
| 05/14/2003 | EP1310166A1 Transgenic non-human mammal and method of constructing the same, animal disease model and method of clarifying gene function |
| 05/14/2003 | EP1309871A2 High throughput method and kit |
| 05/14/2003 | EP1309869A1 Designing and screening random libraries of compounds |
| 05/14/2003 | EP1309861A1 Functional protein arrays |
| 05/14/2003 | EP1309730A2 New hydrazide building blocks and hydrazide modified biomolecules |
| 05/14/2003 | EP1309726A2 Rna sequence-specific mediators of rna interference |
| 05/14/2003 | EP1309725A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human fetal liver |
| 05/14/2003 | EP1309724A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells |
| 05/14/2003 | EP1309723A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and hbl 100 cells |
| 05/14/2003 | EP1309722A1 Use of microbial dna sequences for the identification of human diseases |
| 05/14/2003 | EP1309721A2 Modulating multiple lineage kinase proteins |
| 05/14/2003 | EP1309718A2 Neutrokine-alpha and neutrokine-alpha splice variant |
| 05/14/2003 | EP1309716A2 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 05/14/2003 | EP1309712A2 Composition and method for increased meiotic recombination in plants |
| 05/14/2003 | EP1309711A2 Inhibition of generative propagation in genetically modified herbicide resistant grasses |
| 05/14/2003 | EP1309710A2 Inhibition of generative propagation in genetically modified grasses |
| 05/14/2003 | EP1309709A2 Methods for the replacement, translocation and stacking of dna in eukaryotic genomes |
| 05/14/2003 | EP1309708A2 Method for altering degradation of engineered protein in plant cells |
| 05/14/2003 | EP1309707A1 Assays for alternative lengthening of telomeres |
| 05/14/2003 | EP1309706A2 Modulation of stem cell differentiation |
| 05/14/2003 | EP1309705A2 Multivalent target binding protein |
| 05/14/2003 | EP1309704A2 Regulation of human membrane-type serine protease |
| 05/14/2003 | EP1309703A2 Kallikrein gene |
| 05/14/2003 | EP1309702A2 18806,trypsin serine protease-like molecule and uses thereof |
| 05/14/2003 | EP1309701A2 Myrosinase from brevicoryne brassicae |
| 05/14/2003 | EP1309700A2 Human phosphodiesterases |
| 05/14/2003 | EP1309699A2 Elongase genes and uses thereof |
| 05/14/2003 | EP1309698A2 A cytochrome p450 enzyme associated with the synthesis of delta-12 -epoxy groups in fatty acids of plants |
| 05/14/2003 | EP1309697A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 05/14/2003 | EP1309696A2 32140, human aldehyde dehydrogenase and uses therefor |
| 05/14/2003 | EP1309695A2 Polyketides and their synthesis |
| 05/14/2003 | EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 05/14/2003 | EP1309692A2 Anti-il-12 antibodies, compositions, methods and uses |
| 05/14/2003 | EP1309691A2 Anti-tnf antibodies, compositions, methods and uses |
| 05/14/2003 | EP1309690A2 Mfq-111, a novel human gtpase like protein |
| 05/14/2003 | EP1309689A2 Genes involved in immune related responses observed with asthma |
| 05/14/2003 | EP1309688A2 G protein-coupled receptors |
| 05/14/2003 | EP1309687A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 05/14/2003 | EP1309686A2 Slgp protein and nucleic acid molecules and uses therefor |
| 05/14/2003 | EP1309685A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 05/14/2003 | EP1309684A2 Polynucleotides and polypeptides encoded thereby |
| 05/14/2003 | EP1309682A2 Tetraspan protein and uses thereof |
| 05/14/2003 | EP1309681A2 Arrayed collection of genomic clones |
| 05/14/2003 | EP1309680A2 Dna & protein binding miniature proteins |
| 05/14/2003 | EP1309679A2 Human genes and gene expression products |
| 05/14/2003 | EP1309678A2 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed |
| 05/14/2003 | EP1309677A2 Bacillus transformation, transformants and mutant libraries |
| 05/14/2003 | EP1309676A2 Human epithin-like serine protease |
| 05/14/2003 | EP1309675A2 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same |
| 05/14/2003 | EP1309672A1 Method of producing infectious reovirus |
| 05/14/2003 | EP1309626A2 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 05/14/2003 | EP1309625A2 Therapeutic compounds for ovarian cancer |
| 05/14/2003 | EP1309620A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 05/14/2003 | EP1309618A2 Leucine-based motif and clostridial neurotoxins |
| 05/14/2003 | EP1309606A1 T1r taste receptors and genes encoding same |
| 05/14/2003 | EP1309604A2 Phage-dependent superproduction of biologically active protein and peptides |
| 05/14/2003 | EP1309603A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 05/14/2003 | EP1309602A2 Malaria immunogen and vaccine |
| 05/14/2003 | EP1309373A2 Method and composition for altering a t cell mediated pathology |
| 05/14/2003 | EP1309347A2 Method and composition for altering a b cell mediated pathology |
| 05/14/2003 | EP1309346A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 05/14/2003 | EP1309342A2 Production of chimeric human papillomavirus |
| 05/14/2003 | EP1309341A2 Prevention and treatment of alzheimer's disease |
| 05/14/2003 | EP1309340A1 High mannose proteins and methods of making high mannose proteins |
| 05/14/2003 | EP1309240A1 Nucleic acid expression from linear nucleic acids |
| 05/14/2003 | EP1267940B1 Compounds for targeting |
| 05/14/2003 | EP1183393A4 Pcr-based identification of eimeria species and strains |
| 05/14/2003 | EP1162875B1 Plants transformed with thioredoxin |
| 05/14/2003 | EP1140987B1 Peptides for inhibiting hpv e6 proteins |
| 05/14/2003 | EP1124799B1 Method for preparing methionine |
| 05/14/2003 | EP1110089B1 Chemiluminescent immunoassay for detecting the presence of chagas disease analyte in a sample |
| 05/14/2003 | EP1108061B1 Method for amplifying all dna fragments in a sample |
| 05/14/2003 | EP1041996A4 Keratinocyte growth factor-2 formulations |
| 05/14/2003 | EP1036095A4 Oxygen-transporting albumin-based blood replacement composition and blood volume expander |
| 05/14/2003 | EP1007732A4 Evolution of whole cells and organisms by recursive sequence recombination |
| 05/14/2003 | EP0994963B1 Non-invasive prenatal diagnosis |
| 05/14/2003 | EP0991946B1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor |
| 05/14/2003 | EP0990047B1 Methods and compositions for analyzing nucleic acids by mass spectrometry |
| 05/14/2003 | EP0958382B1 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 05/14/2003 | EP0868427B1 Methods for identifying compounds that bind to a target |
| 05/14/2003 | EP0833902B1 Oligonucleotides specific for hepatitis c virus |
| 05/14/2003 | EP0814838B1 Antigen presenting system and activation of t-cells |
| 05/14/2003 | EP0813541B1 Process for producing a protein |
| 05/14/2003 | EP0800575B1 Method for gene transfer into cells activated out of a quiescent state |
| 05/14/2003 | EP0799314B1 PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES |
| 05/14/2003 | EP0793724B1 Oxidoreductase from filamentous fungi, dna coding therefor and cells transformed with said dna |
| 05/14/2003 | EP0672141B1 Methods of preparing soluble, oligomeric proteins |
| 05/14/2003 | EP0666929B1 Method of inhibiting replication of hyperproliferative cells |
| 05/14/2003 | EP0666919B1 Vaccine containing a thiol protease |
| 05/14/2003 | EP0656014B1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 05/14/2003 | EP0640141B1 Nucleic acid fragments and methods for increasing the lysine and threonine content of the seeds of plants |
| 05/14/2003 | EP0437604B1 Recombinant poxvirus and streptococcal m protein vaccine |
| 05/14/2003 | CN1418255A Herpes virus strains for gene therapy |
| 05/14/2003 | CN1418254A Method for remodelling cell wall polysaccharide structures in plants |
| 05/14/2003 | CN1418253A Proteins producing altered immunogenic response and methods of making and using the same |
| 05/14/2003 | CN1418252A Use of paramyxovirus vector in gene transfer into blood vessel |
| 05/14/2003 | CN1418251A Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same |
| 05/14/2003 | CN1418250A Signal sequence trapping |
| 05/14/2003 | CN1418249A Novel subtilase enzymes having an improved wash performance on egg stains |